Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03790163
Other study ID # MFM.IRB,R/18.11.340
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 15, 2019
Est. completion date April 2019

Study information

Verified date December 2018
Source Mansoura University Hospital
Contact Adham Elgeidi
Phone 01061057973
Email elgeidi@doctors.org.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will be conducted to evaluate the effect of different temperature on the spinal anesthesia characteristics and incidence of complications


Description:

Regional anesthesia techniques are also superior to systemic opioids agents with regard the analgesic profile and adverse effects .Spinal anesthesia is the most commonly used technique due to its unmatchable reliability,simplicity and cost-effectiveness. It provides a fast and effective onset of sensory and motor block, excellent muscle relaxation and prolonged postoperative analgesia .

Bupivacaine is commonly used local anesthetics because of its long duration of action and combined motor and sensory blockade. However, it has many drawbacks .It has a high propensity to cause hypotension and bradycardia. There is also cardiac toxicity.Levobupivacaine is an attractive alternative to bupivacaine because of the lower affinity for cardiac sodium channels and reducing the risk of cardiac toxicity.Moreover ,the isobaric levobupivacaine had more stability in cerebrospinal fluid and thus lead to more predictable drug spread, decreasing the incidence of hypotension and bradycardia. But its main disadvantage is the delayed onset .

A number of strategies have been used to hasten the onset of local anesthesia .The addition of fentanyl mixtures of local anesthetics and alkalization of the local anesthetics all shorten the onset time of sensory block. Recently the warming of the anesthetic agents (namely, lidocaine and bupivacaine) to 37° C hastens the sensory block in various surgical settings .

Up till now there is no study suggestive of any appropriate degree of temperature as adjuvant .Hence the present study will be conducted to evaluate the effect of different temperature on spinal anesthesia characteristics and the incidence its complication


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 120
Est. completion date April 2019
Est. primary completion date March 2019
Accepts healthy volunteers No
Gender All
Age group 21 Years to 70 Years
Eligibility Inclusion Criteria:

- ASA-I or II

Exclusion Criteria:

- patient refusal; Any known hypersensitivity or contraindication to levobupivacaine pregnancy bleeding disorders local skin infections. Sepsis at the site of injection Coagulation abnormality Psychiatric disorders

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Levobupivacaine
Drug: levobupivacaine at room temperature ( 23°C) and second group levobupivacaine warmed to the (30°C) while the third group levobupivacaine warmed to the body temperature (37°C)

Locations

Country Name City State
Egypt Adham Elgeidi Mansourah Dakahliah

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to onset of sensory block Defined as the time interval between the end of spinal anesthesia injection and the loss of sensation to pin prick (sensory score=1) For 10 minutes following the spinal anesthesia
Secondary Time to the onset of motor block Defined as the time interval between the end of spinal anesthesia and (motor score=1) within both lower limbs For 10 minutes following the injection of spinal anesthesia
Secondary Duration of sensory block Defined as the interval between the end of spinal anesthesia and complete end of sensory block (sensory score=2) For 24 hours after the spinal anesthesia
Secondary Duration of motor block Defined as the interval between the end of spinal anesthesia and complete recovery of normal motor function (score=0) For 24 hours after the spinal anesthesia
Secondary Post spinal shivering Post spinal shivering will be graded using a scale ( score 0=no shivering ,score 1= no visible muscle activity ,but one or more of piloerection, score 2=muscular activity in only one muscle group,score 3=moderate muscular activity in more than one muscle group but not generalized shaking ,score 4=violent muscular activity that involves entire body ) for 24 hours after spinal anesthesia
See also
  Status Clinical Trial Phase
Recruiting NCT03712111 - Comparison of Vasopressor Boluses for Management of Hypotension After Spinal Anesthesia Phase 4
Completed NCT03792906 - Comparison of Two Norepinephrine Bolus Doses for Management of Post-spinal Hypotension During Cesarean Delivery Phase 4
Completed NCT05502146 - Comparison of Two Different Norepinephrine Bolus Doses for Management of Spinal Anesthesia-Induced Maternal Hypotension Phase 4
Completed NCT03266250 - Transthoracic Echocardiography of Inferior Vena Cava Before Spinal Anesthesia Can Predict Hypotension
Completed NCT04001881 - Echocardiography and Spinal Induced Hypotension.